Prostate Cancer - Results from #21720

Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancer - Abstract December 2, 2013

Management of patients with biochemical recurrence after local therapy for prostate cancer - Abstract December 2, 2013

Use of statins and the risk of death in patients with prostate cancer - Abstract December 2, 2013

The relationship between solar UV exposure, serum vitamin D levels and serum prostate-specific antigen levels, in men from New South Wales, Australia: The CHAMP study - Abstract December 2, 2013

Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer - Abstract December 2, 2013

Diffusion-weighted MRI, (11)C-choline PET and (18)F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma - Abstract December 2, 2013

Focus on the screening for prostate cancer by PSA - Abstract December 2, 2013

The non-hormonal treatment of metastatic prostate cancer - Abstract November 29, 2013

A genome-wide association study of prostate cancer in West African men - Abstract November 29, 2013

Ductal adenocarcinoma of the prostate: Immunohistochemical findings and clinical significance - Abstract November 29, 2013

Early detection, PSA screening, and management of overdiagnosis - Abstract November 29, 2013

Surgical management of prostate cancer - Abstract November 29, 2013

Contemporary issues in radiotherapy for clinically localized prostate cancer - Abstract November 29, 2013

Very-high-risk localized prostate cancer: Definition and outcomes - Abstract November 29, 2013

Next-generation therapy for residual prostate cancer - Abstract November 29, 2013

Monotherapeutic high-dose-rate brachytherapy for prostate cancer: A dose reduction trial - Abstract November 29, 2013

Evaluation of treatment plan quality of IMRT and VMAT with and without flattening filter using Pareto optimal fronts - Abstract November 29, 2013

The hormonal treatment in prostate cancer - Abstract November 29, 2013

Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era - Abstract November 29, 2013

Reference values for the CAVIPRES-30 Questionnaire, a global questionnaire on the health-related quality of life of patients with prostate cancer - Abstract November 29, 2013

Page 1087 of 1436